氯胺酮抗抑郁疗效相关脑功能变化的网络定位
该研究系统综述了18项多模态神经影像研究(440例抑郁症患者、174名健康对照),通过功能连接网络映射将氯胺酮疗效相关脑区定位到一个涉及默认模式、腹侧注意和额顶网络的特定脑网络;该网络对参数扰动稳健、经留一对比验证,且与抑郁症特异性相关,并与亚膝前扣带回和背外侧前额叶等最佳脑刺激靶点吻合。
要点
- 氯胺酮疗效相关异质性脑区可归入一个涉及默认模式、腹侧注意和额顶网络的连接网络。
- 该网络对参数扰动稳健,经留一对比验证,且特异性关联抑郁症。
- 氯胺酮特异性环路主要涵盖亚膝前扣带回和背外侧前额叶,与抑郁症最佳脑刺激靶点一致。
核心结论
- 氯胺酮抗抑郁疗效相关的异质性神经影像发现可统一到一个涉及默认模式、腹侧注意和额顶网络的特定功能脑网络。
- 该网络对参数扰动稳健、经留一对比验证,且与抑郁症特异性相关,并与亚膝前扣带回和背外侧前额叶等最佳脑刺激靶点吻合。
研究设计与样本
- 系统综述多模态神经影像研究,整合氯胺酮治疗抑郁症疗效相关的脑定位发现。
- 采用功能连接网络映射和大规模 normative connectome 数据库,将脑定位映射为氯胺酮功能脑网络。
- 通过参数扰动稳定性评估和留一对比验证检验网络稳健性,并评估其相对其他精神障碍的抑郁症特异性。
- 采用相同方法构建抗抑郁药功能脑网络,以识别氯胺酮特异性脑环路。
主要发现
- 综述纳入18项多模态神经影像研究,共440例抑郁症患者和174名健康对照。
- 异质性脑定位汇聚为一个连接网络,主要涉及默认模式、腹侧注意和额顶网络相关区域。
- 该网络对轻微扰动稳健、经留一对比验证,且特异性关联抑郁症。
- 与抗抑郁药功能脑网络相比,氯胺酮特异性环路主要涵盖亚膝前扣带回和背外侧前额叶等区域,与抑郁症最佳脑刺激位点一致。
临床怎么用
- 从网络视角理解氯胺酮抗抑郁疗效的神经机制,有助于调和既往不一致的神经影像结果。
- 氯胺酮特异性环路涉及的亚膝前扣带回和背外侧前额叶与抑郁症最佳脑刺激位点一致,或可为刺激靶点选择提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although numerous studies have attempted to identify the functional pathways that underlie the rapid antidepressant effects of ketamine, their findings have been inconsistent, limiting our understanding of the neural mechanisms involved. METHODS: In this study, we aimed to delineate a specific brain circuit by integrating diverse functional findings related to ketamine's efficacy in depression. We conducted a systematic review of multimodal neuroimaging studies that reported brain locations associated with ketamine's effects on depression. Using functional connectivity network mapping and a large-scale normative connectome database, we mapped these locations onto a ketamine functional brain network. We tested the robustness of this network by evaluating its stability under parameter perturbations and leave-one-contrast-out validation and assessed its specificity for depression relative to other mental disorders. We further identified a ketamine-specific brain circuit compared with an antidepressant functional brain network constructed using the same methodology. RESULTS: Our review included 18 multimodal neuroimaging studies with 440 individuals with depression and 174 healthy control individuals. The heterogeneous brain locations localized to a connected network primarily involving regions implicated in the default mode, ventral attention, and frontoparietal networks. This network demonstrated robustness to minor perturbations and validation and was specifically linked to depression. Compared with the antidepressant functional brain network, the ketamine-specific brain circuit predominantly encompassed brain regions such as the subgenual cingulate cortex and dorsolateral prefrontal cortex, which aligned with optimal brain stimulation sites for depression. CONCLUSIONS: These findings help reconcile seemingly inconsistent neuroimaging results and provide new insights into the neuropathology of ketamine's therapeutic effects from a network perspective.
引用
- Han S, Tian Y, Yang H, et al. Network Localization of Functional Brain Changes Associated With Ketamine's Therapeutic Effects in Depression. Biol Psychiatry. 2025. PMID: 40518102. doi:10.1016/j.biopsych.2025.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。